Matsudo, Japan

Chiharu Sone


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 370(Granted Patents)


Location History:

  • Matsudo, JP (1982 - 1983)
  • Chiba, JP (1987)

Company Filing History:


Years Active: 1982-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chiharu Sone: Innovator in Pharmaceutical Compositions

Introduction

Chiharu Sone is a notable inventor based in Matsudo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release compositions. With a total of 3 patents to his name, Sone's work is recognized for its innovative approach to medical materials.

Latest Patents

Sone's latest patents focus on sustained release pharmaceutical compositions of solid medical materials. These compositions contain an amorphous solid medical material, polyethylene oxide, and various basic substances. The first embodiment includes a range of compounds such as hydroxypropylmethyl cellulose and citric acid, while the second embodiment specifically addresses the use of amorphous nicardipine or its salts. His work aims to enhance the efficacy and delivery of pharmaceutical agents.

Career Highlights

Chiharu Sone is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in advancing pharmaceutical technologies. His expertise in sustained release formulations has positioned him as a key player in the industry.

Collaborations

Sone has collaborated with notable colleagues, including Hiroitsu Kawata and Masayoshi Aruga. These partnerships have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Chiharu Sone's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…